Delivery Order SPE2DB20D1100-SPE2DB25FE4Z1
Award Date 9/5/25
Potential Completion Date 9/26/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of GAMUNEX-C 10 gram/100 milliliter vials, with a ceiling value of $9,157.05 and an ultimate completion date of August 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin used to treat immunodeficiency and autoimmune...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,468.56 for GAMUNEX-C 1 gram/10 mL vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin used to treat primary immunodeficiency and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of GAMUNEX-C 20 gram/200 mL vials totaling $8,953.05 with a firm fixed price structure. This non-competitive, non-set-aside delivery order is scheduled for completion by October 3, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The product is an immunoglobulin therapy used for treating immunodeficiency disorders and...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials valued at $46,544.00, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. GAMUNEX-C is an immune globulin intravenous therapy used for treating...
- The Defense Logistics Agency awarded a $13,963.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on June 30, 2025, with an ultimate completion date of July 22, 2025. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat various immunodeficiency conditions and autoimmune disorders. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials, with a contract ceiling value of $11,636.00 and an ultimate completion date of June 27, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $56.6K delivery order to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 20 gram/200 milliliter vials on September 9, 2025, with a completion deadline of September 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIg) product used to treat various immunodeficiency conditions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of GAMUNEX-C 5 gram/50 milliliter vials valued at $3,036.70. This non-competitive delivery order, which must be completed by August 15, 2025, represents a firm fixed-price transaction under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed price contract with an ultimate completion date of September 24, 2025, and represents a non-set-aside competitive award. The delivery will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...